$ETTX Entasis Therapeutics Holdings Inc. Insider Trading Week 39/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Entasis Therapeutics Holdings Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Entasis Therapeutics Holdings Inc. in week 39/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Topper James N | Director | Option Exercise | C | 0.00 | 6,651,574 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Topper James N | Director | Option Exercise | C | 0.00 | 5,212,833 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Topper James N | Director | Option Exercise | C | 0.00 | 7,000,000 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Topper James N | Director | Buy | P | 15.00 | 375,887 | 5,638,305 | 1,349,953 | 974.1 K to 1.3 M (+38.59 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Topper James N | Director | Buy | C | 0.00 | 320,898 | 0 | 974,066 | 653.2 K to 974.1 K (+49.13 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Topper James N | Director | Buy | C | 0.00 | 251,487 | 0 | 589,194 | 337.7 K to 589.2 K (+74.47 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Topper James N | Director | Buy | C | 0.00 | 337,707 | 0 | 337,707 | 0 to 337.7 K |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Sofinnova Venture Partners IX, ... | 10% Owner | Option Exercise | C | 0.00 | 9,502,249 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Sofinnova Venture Partners IX, ... | 10% Owner | Option Exercise | C | 0.00 | 7,446,904 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Sofinnova Venture Partners IX, ... | 10% Owner | Buy | P | 15.00 | 337,724 | 5,065,860 | 1,180,178 | 842.5 K to 1.2 M (+40.09 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Sofinnova Venture Partners IX, ... | 10% Owner | Buy | C | 0.00 | 458,425 | 0 | 842,454 | 384 K to 842.5 K (+119.37 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Sofinnova Venture Partners IX, ... | 10% Owner | Buy | C | 0.00 | 359,267 | 0 | 359,267 | 0 to 359.3 K |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Preston Heather | Director | Option Exercise | C | 0.00 | 9,502,249 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Preston Heather | Director | Option Exercise | C | 0.00 | 7,446,904 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Preston Heather | Director | Buy | P | 15.00 | 337,724 | 5,065,860 | 1,180,178 | 842.5 K to 1.2 M (+40.09 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Preston Heather | Director | Buy | C | 0.00 | 458,425 | 0 | 842,454 | 384 K to 842.5 K (+119.37 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Preston Heather | Director | Buy | C | 0.00 | 359,267 | 0 | 359,267 | 0 to 359.3 K |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Pivotal bioVenture Partners Fu ... | 10% Owner | Option Exercise | C | 0.00 | 9,502,249 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Pivotal bioVenture Partners Fu ... | 10% Owner | Option Exercise | C | 0.00 | 7,446,904 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Pivotal bioVenture Partners Fu ... | 10% Owner | Buy | P | 15.00 | 337,724 | 5,065,860 | 1,180,178 | 842.5 K to 1.2 M (+40.09 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Pivotal bioVenture Partners Fu ... | 10% Owner | Buy | C | 0.00 | 458,425 | 0 | 842,454 | 384 K to 842.5 K (+119.37 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Pivotal bioVenture Partners Fu ... | 10% Owner | Buy | C | 0.00 | 359,267 | 0 | 359,267 | 0 to 359.3 K |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | GALAKATOS NICHOLAS | Director | Option Exercise | C | 0.00 | 8,552,024 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | GALAKATOS NICHOLAS | Director | Option Exercise | C | 0.00 | 6,702,213 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | GALAKATOS NICHOLAS | Director | Option Exercise | C | 0.00 | 7,500,000 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | GALAKATOS NICHOLAS | Director | Buy | P | 15.00 | 453,395 | 6,800,925 | 1,623,405 | 1.2 M to 1.6 M (+38.75 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | GALAKATOS NICHOLAS | Director | Buy | C | 0.00 | 412,583 | 0 | 1,170,010 | 757.4 K to 1.2 M (+54.47 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | GALAKATOS NICHOLAS | Director | Buy | C | 0.00 | 323,341 | 0 | 685,170 | 361.8 K to 685.2 K (+89.36 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | GALAKATOS NICHOLAS | Director | Buy | C | 0.00 | 361,829 | 0 | 361,829 | 0 to 361.8 K |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 6,651,574 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 5,212,833 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Option Exercise | C | 0.00 | 7,000,000 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | P | 15.00 | 375,887 | 5,638,305 | 1,349,953 | 974.1 K to 1.3 M (+38.59 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | C | 0.00 | 320,898 | 0 | 974,066 | 653.2 K to 974.1 K (+49.13 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | C | 0.00 | 251,487 | 0 | 589,194 | 337.7 K to 589.2 K (+74.47 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Frazier Life Sciences VIII, L. ... | 10% Owner | Buy | C | 0.00 | 337,707 | 0 | 337,707 | 0 to 337.7 K |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 8,552,024 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 6,702,213 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Clarus Lifesciences III, L.P. | 10% Owner | Option Exercise | C | 0.00 | 7,500,000 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | P | 15.00 | 453,395 | 6,800,925 | 1,623,405 | 1.2 M to 1.6 M (+38.75 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 412,583 | 0 | 1,170,010 | 757.4 K to 1.2 M (+54.47 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 323,341 | 0 | 685,170 | 361.8 K to 685.2 K (+89.36 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | Clarus Lifesciences III, L.P. | 10% Owner | Buy | C | 0.00 | 361,829 | 0 | 361,829 | 0 to 361.8 K |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | ASTRAZENECA PLC | 10% Owner | Option Exercise | C | 0.00 | 33,499,900 | 0 | 0 | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | ASTRAZENECA PLC | 10% Owner | Buy | P | 15.00 | 246,666 | 3,699,990 | 2,164,855 | 1.9 M to 2.2 M (+12.86 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | ASTRAZENECA PLC | 10% Owner | Buy | C | 0.00 | 1,918,185 | 0 | 1,918,189 | 4 to 1.9 M (+47,954,625.00 %) |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | TPG Group Holdings (SBS) Advis ... | Option Exercise | C | 0.00 | 15,254,237 | 0 | 0 | ||
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | TPG Group Holdings (SBS) Advis ... | Buy | P | 15.00 | 262,539 | 3,938,085 | 1,020,748 | 758.2 K to 1 M (+34.63 %) | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | TPG Group Holdings (SBS) Advis ... | Buy | J | 0.00 | 22,285 | 0 | 758,209 | 735.9 K to 758.2 K (+3.03 %) | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | TPG Group Holdings (SBS) Advis ... | Buy | C | 0.00 | 735,924 | 0 | 735,924 | 0 to 735.9 K | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | TPG Group Holdings (SBS) Advis ... | Option Exercise | C | 0.00 | 15,254,237 | 0 | 0 | ||
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | TPG Group Holdings (SBS) Advis ... | Buy | P | 15.00 | 262,539 | 3,938,085 | 1,020,748 | 758.2 K to 1 M (+34.63 %) | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | TPG Group Holdings (SBS) Advis ... | Buy | J | 0.00 | 22,285 | 0 | 758,209 | 735.9 K to 758.2 K (+3.03 %) | |
| Oct 02 2018 | ETTX | Entasis Therapeuti ... | TPG Group Holdings (SBS) Advis ... | Buy | C | 0.00 | 735,924 | 0 | 735,924 | 0 to 735.9 K | |
| Oct 01 2018 | ETTX | Entasis Therapeuti ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 14,237,288 | 0 | 0 | |
| Oct 01 2018 | ETTX | Entasis Therapeuti ... | Novo Holdings A/S | 10% Owner | Option Exercise | C | 0.00 | 7,000,000 | 0 | 0 | |
| Oct 01 2018 | ETTX | Entasis Therapeuti ... | Novo Holdings A/S | 10% Owner | Buy | P | 15.00 | 1,089,835 | 16,347,525 | 2,181,843 | 1.1 M to 2.2 M (+99.80 %) |
| Oct 01 2018 | ETTX | Entasis Therapeuti ... | Novo Holdings A/S | 10% Owner | Buy | C | 0.00 | 1,092,008 | 0 | 1,092,008 | 0 to 1.1 M |